New drugs on the horizon in bronchogenic carcinoma.
D000588:Amines / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D002330:Carmustine / Q000627:therapeutic use; D003498:Cyclic P-Oxides / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004123:Dimethylamines / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005021:Ethylamines / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006801:Humans; D007659:Ketones / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D010984:Platinum / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use
D000588:Amines; D000970:Antineoplastic Agents; D003498:Cyclic P-Oxides; D004123:Dimethylamines; D005021:Ethylamines; D007659:Ketones; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; D010078:Oxazines; D010879:Piperazines; D014227:Triazines; D001761:Bleomycin; D010984:Platinum; D004317:Doxorubicin; D003520:Cyclophosphamide; D001374:Azacitidine; D002330:Carmustine